Who earns more money from generic drug sales: PBMs or drug manufacturers?
If you guessed manufacturers, you would be incorrect. At least that is according to a new study by Mattingly et al. (2023) in JAMA Health Forum. Using a sample of the 45 generic drugs with >$100m in Part D and used by >1m beneficiaries, the authors found that: …Medicare Part D spent $11.8 billion for…